27.07.2022 • News

Solvay Plans US Electronic-grade Hydrogen Peroxide Plant

Solvay has announced plans to build a new plant in Casa Grande, Arizona, USA, for producing electronic-grade hydrogen peroxide. The investment in its seventh such unit has been prompted by growing demand from the US semiconductor industry.

The plant, which will be fully powered using renewable electricity, will convert hydrogen peroxide into an ultra-high purity grade to clean the silicon wafers necessary for making the semiconductors, which are essential components in electronic devices.

“This investment will grow our presence in the North American semiconductor market,” said CEO Ilham Kadri. “The new facility will help us to further tap into increasing demand from the domestic electronic industry, and our local customers will likewise gain even better access to our products and services. This will help us meet their increasing demand for chemicals that are essential for cleaning and etching large-scale integrated circuits and semiconductors.”

Solvay has bought 25 acres of greenfield land within Casa Grande’s Central Arizona Commerce Park and construction of the first production line is scheduled to begin in 2023. Future expansions will be built as needed to support customer demand. The facility will also create 30 full-time jobs.  

The Belgian group announced in March this year that it was exploring options to split into two publicly listed companies. If the plans proceed, the spinoffs will take effect in the second half of 2023. One of the spinoffs would include Solvay’s peroxides, soda ash, silica, specialty chemicals and Coatis businesses, while the other would comprise specialty polymers, composites and most of its solutions segment, which includes Novecare, technology solutions, aroma performance and oil & gas.

Author: Elaine Burridge, Freelance Journalist

© Solvay
© Solvay

Company

Logo:

Solvay

Rue du Prince Albert 33
1050 Bruxelles
Belgium

Company contact







Expert Insights

ADCs for Precision Cancer Therapy
Comprehensive Insights into Antibody–Drug Conjugates

ADCs for Precision Cancer Therapy

Explore how antibody-drug conjugates are reshaping precision cancer therapy and discover what it takes to successfully develop, manufacture, and scale these complex biologics.

Interview

Driving Transformation
Interconnected Global Chemicals Logistics

Driving Transformation

DP World is reshaping global chemical supply chains. Christene Smith of CHEManager interviews Markus Kanis, Global SVP Chemicals, on the company’s roadmap, new technologies, and the evolving demands of global trade.

most read

Photo

VCI Welcomes US-EU Customs Deal

The German Chemical Industry Association (VCI) welcomes the fact that Ursula von der Leyen, President of the European Commission, and US President Donald Trump have averted the danger of a trade war for the time being.